Clinical Trials Logo
  1. Home
  2. Hirsutism
  3. NCT00152048

Evaluation of Eflornithine on Facial and Forearm Skin

Hirsutism Clinical Trial

Official title:
A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair

Clinical Trial Summary

The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00152048
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date November 30, 2004
Completion date October 31, 2005
View Details
See also
  Status Clinical Trial Phase
Completed NCT02103608 - Clinical Evaluation of Silk'n Glide for Face N/A
Not yet recruiting NCT00495443 - Enhanced Safety Aesthetic Laser System N/A
Not yet recruiting NCT06003062 - Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
Active, not recruiting NCT00145288 - Prospective Study of Patients With Hirsutism Phase 2/Phase 3
Enrolling by invitation NCT01461694 - Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser Phase 2/Phase 3
Not yet recruiting NCT00441948 - Enhanced Safety Laser Hair Removal System N/A
Completed NCT03673995 - Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS N/A
Recruiting NCT04979377 - Prevalence of Hyperandrogenism in Type 1 Diabetes
Completed NCT02494297 - DUS on the Prescribing Indications for CPA/EE in 5 European Countries
Completed NCT00960310 - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions Phase 1
Completed NCT02793557 - Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth Phase 1/Phase 2
Completed NCT01817894 - Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism Phase 4
Completed NCT01555190 - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone N/A
Completed NCT00143052 - Bone Status and Insulin Resistance in Hirsutism N/A
Recruiting NCT01338519 - Database Study on Patients With PCOS N/A
Recruiting NCT04292587 - Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
Completed NCT00959335 - Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions Phase 1
Not yet recruiting NCT00371930 - Photodynamic Therapy for Permanent Hair Removal Phase 1/Phase 2